Furthermore, decreased FNDC3Awas found to be related with a poor RFS or OS in all subtypes of patients apart from luminal B. It’s worth noting that high FNDC3B expression was probably tied to completely opposite survival outcomes in different breast cancer subtypes and survival analysis methods. This evidence concerns the gene FNDC3B and breast carcinoma.